Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. [electronic resource]
Producer: 20210118Description: 320 p. digitalISSN:- 1745-6215
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy -- methods
- Chemotherapy, Adjuvant
- Clinical Trials, Phase II as Topic
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Fluorouracil -- therapeutic use
- Humans
- Leucovorin -- therapeutic use
- Multicenter Studies as Topic
- Neoadjuvant Therapy -- methods
- Neoplasm Invasiveness
- Neoplasm Staging
- Organoplatinum Compounds -- therapeutic use
- Preoperative Care -- methods
- Prognosis
- Prospective Studies
- Randomized Controlled Trials as Topic
- Rectal Neoplasms -- drug therapy
- Republic of Korea
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial Protocol; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.